157 related articles for article (PubMed ID: 30141910)
21. Design of Small Molecules That Compete with Nucleotide Binding to an Engineered Oncogenic KRAS Allele.
Zhang Y; Larraufie MH; Musavi L; Akkiraju H; Brown LM; Stockwell BR
Biochemistry; 2018 Feb; 57(8):1380-1389. PubMed ID: 29313669
[TBL] [Abstract][Full Text] [Related]
22. KRAS
Cagir A; Azmi AS
Future Med Chem; 2019 May; 11(9):923-925. PubMed ID: 31140867
[No Abstract] [Full Text] [Related]
23. The RAS-Binding Domain of Human BRAF Protein Serine/Threonine Kinase Exhibits Allosteric Conformational Changes upon Binding HRAS.
Aramini JM; Vorobiev SM; Tuberty LM; Janjua H; Campbell ET; Seetharaman J; Su M; Huang YJ; Acton TB; Xiao R; Tong L; Montelione GT
Structure; 2015 Aug; 23(8):1382-1393. PubMed ID: 26165597
[TBL] [Abstract][Full Text] [Related]
24. Allosteric effects of the oncogenic RasQ61L mutant on Raf-RBD.
Fetics SK; Guterres H; Kearney BM; Buhrman G; Ma B; Nussinov R; Mattos C
Structure; 2015 Mar; 23(3):505-516. PubMed ID: 25684575
[TBL] [Abstract][Full Text] [Related]
25. Three-dimensional structures and properties of a transforming and a nontransforming glycine-12 mutant of p21H-ras.
Franken SM; Scheidig AJ; Krengel U; Rensland H; Lautwein A; Geyer M; Scheffzek K; Goody RS; Kalbitzer HR; Pai EF
Biochemistry; 1993 Aug; 32(33):8411-20. PubMed ID: 8357792
[TBL] [Abstract][Full Text] [Related]
26. Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets.
Moodie SA; Paris M; Villafranca E; Kirshmeier P; Willumsen BM; Wolfman A
Oncogene; 1995 Aug; 11(3):447-54. PubMed ID: 7630628
[TBL] [Abstract][Full Text] [Related]
27. Molecular dynamics simulations of the Ras:Raf and Rap:Raf complexes.
Zeng J; Treutlein HR; Simonson T
Proteins; 1999 Apr; 35(1):89-100. PubMed ID: 10090289
[TBL] [Abstract][Full Text] [Related]
28. Elucidating the mode of action of a typical Ras state 1(T) inhibitor.
Rosnizeck IC; Filchtinski D; Lopes RP; Kieninger B; Herrmann C; Kalbitzer HR; Spoerner M
Biochemistry; 2014 Jun; 53(24):3867-78. PubMed ID: 24866928
[TBL] [Abstract][Full Text] [Related]
29. GTP-dependent association of Raf-1 with Ha-Ras: identification of Raf as a target downstream of Ras in mammalian cells.
Koide H; Satoh T; Nakafuku M; Kaziro Y
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8683-6. PubMed ID: 8378348
[TBL] [Abstract][Full Text] [Related]
30. Assignments of backbone ¹H, ¹³C and ¹⁵N resonances in H-Ras (1-166) complexed with GppNHp at physiological pH.
O'Connor C; Kovrigin EL
Biomol NMR Assign; 2012 Apr; 6(1):91-3. PubMed ID: 21814767
[TBL] [Abstract][Full Text] [Related]
31. NMR
Sharma AK; Lee SJ; Zhou M; Rigby AC; Townson SA
Biomol NMR Assign; 2019 Apr; 13(1):227-231. PubMed ID: 30798456
[TBL] [Abstract][Full Text] [Related]
32. Oncogenic mutations Q61L and Q61H confer active form-like structural features to the inactive state (state 1) conformation of H-Ras protein.
Matsumoto S; Taniguchi-Tamura H; Araki M; Kawamura T; Miyamoto R; Tsuda C; Shima F; Kumasaka T; Okuno Y; Kataoka T
Biochem Biophys Res Commun; 2021 Aug; 565():85-90. PubMed ID: 34102474
[TBL] [Abstract][Full Text] [Related]
33. Nuclear magnetic resonance and molecular dynamics studies on the interactions of the Ras-binding domain of Raf-1 with wild-type and mutant Ras proteins.
Terada T; Ito Y; Shirouzu M; Tateno M; Hashimoto K; Kigawa T; Ebisuzaki T; Takio K; Shibata T; Yokoyama S; Smith BO; Laue ED; Cooper JA
J Mol Biol; 1999 Feb; 286(1):219-32. PubMed ID: 9931261
[TBL] [Abstract][Full Text] [Related]
34. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro.
Warne PH; Viciana PR; Downward J
Nature; 1993 Jul; 364(6435):352-5. PubMed ID: 8332195
[TBL] [Abstract][Full Text] [Related]
35. X-ray crystal structures reveal two activated states for RhoC.
Dias SM; Cerione RA
Biochemistry; 2007 Jun; 46(22):6547-58. PubMed ID: 17497936
[TBL] [Abstract][Full Text] [Related]
36. Conformational states of human rat sarcoma (Ras) protein complexed with its natural ligand GTP and their role for effector interaction and GTP hydrolysis.
Spoerner M; Hozsa C; Poetzl JA; Reiss K; Ganser P; Geyer M; Kalbitzer HR
J Biol Chem; 2010 Dec; 285(51):39768-78. PubMed ID: 20937837
[TBL] [Abstract][Full Text] [Related]
37. Crystal structures of Ral-GppNHp and Ral-GDP reveal two binding sites that are also present in Ras and Rap.
Nicely NI; Kosak J; de Serrano V; Mattos C
Structure; 2004 Nov; 12(11):2025-36. PubMed ID: 15530367
[TBL] [Abstract][Full Text] [Related]
38. Regional polysterism in the GTP-bound form of the human c-Ha-Ras protein.
Ito Y; Yamasaki K; Iwahara J; Terada T; Kamiya A; Shirouzu M; Muto Y; Kawai G; Yokoyama S; Laue ED; Wälchli M; Shibata T; Nishimura S; Miyazawa T
Biochemistry; 1997 Jul; 36(30):9109-19. PubMed ID: 9230043
[TBL] [Abstract][Full Text] [Related]
39. Critical roles of interactions among switch I-preceding residues and between switch II and its neighboring alpha-helix in conformational dynamics of the GTP-bound Ras family small GTPases.
Matsumoto K; Shima F; Muraoka S; Araki M; Hu L; Ijiri Y; Hirai R; Liao J; Yoshioka T; Kumasaka T; Yamamoto M; Tamura A; Kataoka T
J Biol Chem; 2011 Apr; 286(17):15403-12. PubMed ID: 21388959
[TBL] [Abstract][Full Text] [Related]
40. Revealing the mechanism of action of a first-in-class covalent inhibitor of KRASG12C (ON) and other functional properties of oncogenic KRAS by
Sharma AK; Pei J; Yang Y; Dyba M; Smith B; Rabara D; Larsen EK; Lightstone FC; Esposito D; Stephen AG; Wang B; Beltran PJ; Wallace E; Nissley DV; McCormick F; Maciag AE
J Biol Chem; 2024 Feb; 300(2):105650. PubMed ID: 38237681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]